Pediatrics

Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2


Immune thrombocytopenia (ITP) is a potential presentation of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing should be considered in these patients to allow for appropriate hospital triaging and isolation to limit community spread and health care worker infection during epidemics or pandemics. ITP is characterized by isolated thrombocytopenia. Approximately two-thirds of children with primary ITP have a history of a viral infection during the previous month.1,2 Viruses commonly identified as triggers include cytomegalovirus, hepatitis C, herpes, varicella zoster, Epstein-Barr, influenza, and HIV.3–7 In this case report, we describe the first documented case of a pediatric patient with ITP who tested positive for SARS-CoV-2. This case raises awareness of ITP as a possible pediatric presentation of coronavirus disease.

Source link

Related posts

Pioneering Gene Therapy by UCSF Benioff Children’s Hospital Oakland Researchers Demonstrates Therapy Can Eliminate Life-Long Need for Transfusions in Patients with Incurable Blood Disorder

Newsemia

Screening Pediatric Patients in New-Onset Syncope (SPINS) Study

Newsemia

Telehealth Services Rapidly Expand at Nationwide Children's Hospital Amid COVID-19 Response

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World